Concepedia

Renato Mantegazza

RM

224

Publications

13.7K

Citations

63

H-Index

1984

Active since

Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta(Current)

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

University of North Carolina at Chapel Hill

Università Cattolica del Sacro Cuore

Renato Mantegazza is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1984–2024

224

Publications

224

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

,

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

Ezio Gerdoni, Barbara Gallo, Simona Casazza et al. · Annals of Neurology · 2007 · 481 citations · Full text

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

Paraskevi Zisimopoulou, Panagiota Evangelakou, John Tzartos et al. · Journal of Autoimmunity · 2013 · 317 citations · Full text

, , +4

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

Donald B. Sanders, I. K. Hart, Renato Mantegazza et al. · Neurology · 2008 · 308 citations

Rows per page

1–5 of 224